Concepedia

The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines

Daan J.A. Crommelin, David B. Volkin, Karin H. Hoogendoorn, A. S. Lubiniecki, Wim Jiskoot

Journal of Pharmaceutical Sciences · 2020 · 60 citations · 14 references

DOIFull text

Open access

Concepts

References

14

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan et al. · The Lancet · 2020 · 1.5K citations · Full text

, , +17

Development of stable liquid formulations for adenovirus-based vaccines

Robert K. Evans, Denise K. Nawrocki, Lynne A. Isopi et al. · Journal of Pharmaceutical Sciences · 2004 · 165 citations

, , +14

Formulation, Stability, and Delivery of Live Attenuated Vaccines for Human Use

David B. Volkin, Tsu-An Hsu, Carl J. Burke · Critical Reviews in Therapeutic Drug Carrier Systems · 1999 · 92 citations

, , +17

Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying

Phillip M. Lovalenti, Jeff N. Anderl, Luisa Yee et al. · Pharmaceutical Research · 2016 · 61 citations

, , +17

Towards ambient temperature-stable vaccines: The identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay

Lisa D. Schlehuber, Iain J. McFadyen, Yu Shu et al. · Vaccine · 2011 · 60 citations · Full text

, , +17